TAPSE/PASP ratio

1. TAPSE/PASP ratio is associated with stroke volume in humans (Hospitalization for acute heart failure) (ρ = +0.392, p < 0.001).

   “higher values correlated positively with LVEF (ρ = +0.269, p = 0.017), stroke volume (ρ = +0.392, p < 0.001)”

   HumansHospitalization for acute heart failureheartn = 79

   Right ventricular–arterial uncoupling identifies acute heart failure patients with reduced tolerance to GDMT

   ESC Congress 2026 abstract·Oct 26, 2026

More on Stroke volume

1. TAPSE/PASP ratio is associated with Therapy Optimization Score in humans (ρ = +0.340, p = 0.002).

   “higher values correlated positively with LVEF (ρ = +0.269, p = 0.017), stroke volume (ρ = +0.392, p < 0.001), and Therapy Optimization Score (ρ = +0.340, p = 0.002).”

   HumansHospitalization for acute heart failure; admission TAPSE/PASP and discharge therapy optimizationn = 79

   Right ventricular–arterial uncoupling identifies acute heart failure patients with reduced tolerance to GDMT

   ESC Congress 2026 abstract·Oct 26, 2026

More on Therapy Optimization Score

1. TAPSE/PASP ratio is linked with a lower risk of mortality in humans (HR 0.856, 95% CI 0.743-0.988 per 0.1 mm/mmHg increase).

   “postoperative TAPSE/PASP (HR = 0.856 per 0.1 mm/mm Hg increase, P = .033, 95% CI: 0.743-0.988) remained independent predictors of long-term mortality.”

   Humans509 daysn = 786

   Postoperative Right Ventriculo-Pulmonary Artery Coupling Assessed by TAPSE/PASP as a Predictor of Long-Term Outcomes After TAVI

   Anatolian journal of cardiology·Mar 1, 2026